Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | T-cell surface glycoprotein CD3 epsilon chain inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
| Arthritis, Psoriatic | 2 | D015535 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109253 |
CONTENTS